financetom
Business
financetom
/
Business
/
Major Cannabis Merger Approved In New York: Can Weed Stock Investors Take Advantage?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Major Cannabis Merger Approved In New York: Can Weed Stock Investors Take Advantage?
Oct 10, 2024 11:44 PM

RIV Capital Inc. ( CNPOF ) (OTC:CNPOF) and Cansortium Inc. ( CNTMF ) have secured approval from the New York Cannabis Control Board for their upcoming merger, marking a major consolidation in the state's fast-growing cannabis industry.

The merger, expected to close by the end of 2024, positions the combined company to take full advantage of covering 25% of the U.S. population with eight cultivation and processing facilities and 42 retail dispensaries.

“We are thrilled to have received regulatory approval in New York to move forward with our business combination transaction, bringing us closer to completing this important step for both of our companies in the fourth quarter of 2024,” said Robert Beasley, CEO of Cansortium ( CNTMF ), in a press release Thursday afternoon.

Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. You can’t afford to miss out if you're serious about the business.

New York's Cannabis Boom

With adult-use cannabis sales now in full swing, New York has quickly become a battleground for companies looking to expand their market share. RIV Capital ( CNPOF ), which operates three retail locations in the state, has seen rapid growth in both its consumer-facing and wholesale businesses since adult-use sales began earlier this year.

Cansortium ( CNTMF ), a vertically integrated company operating under the FLUENT™ brand, brings significant expertise from other key markets, including Florida, Pennsylvania, and Texas.

Read Also: EXCLUSIVE: 80% Growth Despite The Chaos: How Dutchie, C3 Defy 2024’s Cannabis Slump

What This Means For Investors

For cannabis investors, this merger signals a unique opportunity to gain exposure to a rapidly expanding market. RIV Capital's ( CNPOF ) partnership with The Hawthorne Collective, a subsidiary of ScottsMiracle-Gro , further strengthens its position in the cannabis supply chain. Meanwhile, Cansortium's ( CNTMF ) operational expertise in cultivation, production and retail will likely drive significant value for shareholders.

Closing Timeline And Further Details

The merger between RIV Capital ( CNPOF ) and Cansortium ( CNTMF ) is expected to close by the fourth quarter of 2024, pending final closing conditions.

Upon completion, Cansortium’s shares will continue trading on the Canadian Securities Exchange under the symbol ‘TIUM.U’ and on the OTCQB Venture Market under ‘CNTMF.’

Further details, including the principal closing conditions, can be found in RIV Capital’s management information circular dated July 12, 2024.

Read Next: Tilray Reports $200M Q1 Net Revenue, Up 13% YoY As Net Loss Improves

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Itron Insider Sold Shares Worth $3,930,998, According to a Recent SEC Filing
Itron Insider Sold Shares Worth $3,930,998, According to a Recent SEC Filing
Oct 3, 2024
12:30 PM EDT, 10/03/2024 (MT Newswires) -- Thomas Deitrich, Director, President & CEO, on October 01, 2024, sold 37,500 shares in Itron ( ITRI ) for $3,930,998. Following the Form 4 filing with the SEC, Deitrich has control over a total of 230,276 shares of the company, with 205,276 shares held directly and 25,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/780571/000112760224025027/xslF345X05/form4.xml Price:...
Correction: Hims & Hers Health Shares Fall After Weight-Loss Drug Shortage Ends
Correction: Hims & Hers Health Shares Fall After Weight-Loss Drug Shortage Ends
Oct 3, 2024
12:23 PM EDT, 10/03/2024 (MT Newswires) -- (Corrects Novo Nordisk's ticker symbol in the last paragraph.) Hims & Hers Health ( HIMS ) shares fell by nearly 9% in Thursday's premarket activity a day after the US Food and Drug Administration said that a shortage of tirzepatide injection medication has been resolved. The FDA said the weight-loss drug has been...
--Blue Owl Capital in Talks to Acquire IPI Partners for $1 Billion, Bloomberg Reports
--Blue Owl Capital in Talks to Acquire IPI Partners for $1 Billion, Bloomberg Reports
Oct 3, 2024
12:30 PM EDT, 10/03/2024 (MT Newswires) -- Price: 19.90, Change: +0.20, Percent Change: +1.02 ...
Huntington Ingalls Wins Research Project With Defense Department
Huntington Ingalls Wins Research Project With Defense Department
Oct 3, 2024
12:19 PM EDT, 10/03/2024 (MT Newswires) -- Huntington Ingalls Industries ( HII ) said Thursday that its Mission Technologies division won a task order to enhance navigation and autonomy technologies for the US Department of Defense and specifically for the US Air Force. A Huntington Ingalls team at Wright-Patterson Air Force Base in Dayton, Ohio, will conduct research for the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved